FR2662360B1 - COMPOUNDS FOR INCLUDING NIMESULIDE WITH CYCLODEXTRIN, METHODS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS WITH ANALGESIC AND ANTI-INFLAMMATORY ACTIVITY CONTAINING THE SAME. - Google Patents

COMPOUNDS FOR INCLUDING NIMESULIDE WITH CYCLODEXTRIN, METHODS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS WITH ANALGESIC AND ANTI-INFLAMMATORY ACTIVITY CONTAINING THE SAME.

Info

Publication number
FR2662360B1
FR2662360B1 FR9106165A FR9106165A FR2662360B1 FR 2662360 B1 FR2662360 B1 FR 2662360B1 FR 9106165 A FR9106165 A FR 9106165A FR 9106165 A FR9106165 A FR 9106165A FR 2662360 B1 FR2662360 B1 FR 2662360B1
Authority
FR
France
Prior art keywords
analgesic
cyclodextrin
compounds
preparation
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9106165A
Other languages
French (fr)
Other versions
FR2662360A1 (en
Inventor
Sicart Girona Isidro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LEETRIM Ltd
Original Assignee
LEETRIM Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LEETRIM Ltd filed Critical LEETRIM Ltd
Publication of FR2662360A1 publication Critical patent/FR2662360A1/en
Application granted granted Critical
Publication of FR2662360B1 publication Critical patent/FR2662360B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
FR9106165A 1990-05-22 1991-05-22 COMPOUNDS FOR INCLUDING NIMESULIDE WITH CYCLODEXTRIN, METHODS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS WITH ANALGESIC AND ANTI-INFLAMMATORY ACTIVITY CONTAINING THE SAME. Expired - Fee Related FR2662360B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9001566A ES2023552A6 (en) 1990-05-22 1990-05-22 Nimesulid inclusion cpds. with cyclodextrin - more water-soluble with improved bio-availability than nimesulid alone

Publications (2)

Publication Number Publication Date
FR2662360A1 FR2662360A1 (en) 1991-11-29
FR2662360B1 true FR2662360B1 (en) 1993-07-30

Family

ID=8267635

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9106165A Expired - Fee Related FR2662360B1 (en) 1990-05-22 1991-05-22 COMPOUNDS FOR INCLUDING NIMESULIDE WITH CYCLODEXTRIN, METHODS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS WITH ANALGESIC AND ANTI-INFLAMMATORY ACTIVITY CONTAINING THE SAME.

Country Status (4)

Country Link
DE (1) DE4116659C2 (en)
ES (1) ES2023552A6 (en)
FR (1) FR2662360B1 (en)
IT (1) IT1255982B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1255462B (en) * 1992-07-28 1995-11-02 Grazia Maffione METHOD OF PREPARATION OF NIMESULIDE INCLUSION COMPOUNDS WITH CYCLODESTRINE
IT1291278B1 (en) * 1996-07-05 1999-01-07 Errekappa Euroterapici S P A NIMESULIDE-BASED PHARMACEUTICAL PREPARATION FOR TOPICAL USE
IN186315B (en) * 1996-12-12 2001-08-04 Panacea Biotec Ltd
IT1291895B1 (en) * 1997-04-24 1999-01-21 Errekappa Euroterapici S P A FLUID PHARMACEUTICAL PREPARATION BASED ON NIMESULIDE FOR ORAL AND RHINOPHARYNGAL USE
CA2649620A1 (en) * 2006-04-24 2007-11-01 Panacea Biotec Ltd. Novel low dose pharmaceutical compositions comprising nimesulide, preparation and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR206496A1 (en) * 1972-07-03 1976-07-30 Riker Laboratories Inc PROCEDURE FOR THE PREPARATION OF 2-PHENOXY-4-NITRO-ALKYL OR HALOALKYLSULPHONANILIDES
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition

Also Published As

Publication number Publication date
ES2023552A6 (en) 1992-01-16
DE4116659A1 (en) 1991-11-28
DE4116659C2 (en) 2000-11-16
ITMI911396A1 (en) 1992-11-21
FR2662360A1 (en) 1991-11-29
IT1255982B (en) 1995-11-17
ITMI911396A0 (en) 1991-05-21

Similar Documents

Publication Publication Date Title
FR2677984B1 (en) N-SUBSTITUTED IMIDAZOLINE DERIVATIVES, THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
MC2077A1 (en) BENZOIC AND PHENYLACETIC DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2761266B1 (en) PHARMACEUTICAL COMPOSITION FORMED BY WET GRANULATION FOR THE ORAL ADMINISTRATION OF A DERIVATIVE OF N-PIPERIDINO-3- PYRAZOLECARBOXAMIDE, ITS SALTS AND THEIR SOLVATES
FR2761265B1 (en) PHARMACEUTICAL COMPOSITION FOR THE ORAL ADMINISTRATION OF A DERIVATIVE OF N-PIPERIDINO-3-PYRAZOLECARBOXAMIDE, ITS SALTS AND THEIR SOLVATES
MA26516A1 (en) TARTRATE OF A SUBSTITUTED DIPEPTIDE, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
MA26445A1 (en) AZABICYCLIC COMPOUNDS CONDENSED WITH A PYRIDONE CORE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
ITMI940326A0 (en) DERIVATIVES OF 3,8-DIAZABICYCLE [3.2.1.] FIGHT ANALGESIC ACTIVITY
IT1212778B (en) PHARMACEUTICAL COMPOSITIONS ANTI-INFLAMMATORY AND / OR ANALGESIC ADAPTERITY, NON ULCEROGENE.
IT1226549B (en) PHARMACEUTICAL COMPOSITIONS WITH ANALGESIC AND ANTI-INFLAMMATORY ACTIVITY FOR ORAL USE, EQUIPPED WITH EXCELLENT PALATABILITY AND FREE FROM IRRITATING EFFECTS ON MUCOSES.
IT1243342B (en) ORAL PHARMACEUTICAL COMPOSITIONS FOR LIQUID ANTI-INFLAMMATORY ACTIVITIES
MA26519A1 (en) AZETIDINYLPROPYLPIPERIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2687401B1 (en) 1,4-DIALKYLPIPERAZINE DERIVATIVES, PROCESSES FOR OBTAINING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
FR2662360B1 (en) COMPOUNDS FOR INCLUDING NIMESULIDE WITH CYCLODEXTRIN, METHODS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS WITH ANALGESIC AND ANTI-INFLAMMATORY ACTIVITY CONTAINING THE SAME.
MA26708A1 (en) NEW INDOLE DERIVATIVE, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2505826B1 (en) ISOPRENYLAMINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS PREPARED THEREWITH
MA26469A1 (en) 5-AROYLNAPHTHALENE DERIVATIVES WITH ANTI-INFLAMMATORY AND ANALGESIC ACTION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND METHODS OF USING AND PREPARING THEM.
FR2660195B1 (en) PHARMACEUTICAL CHEWING, ANTI-INFLAMMATORY AND / OR ANALGESIC COMPOSITION.
IT1211135B (en) ANALGESIC AND ANTI-INFLAMMATORY ACTIVITY COMPOUNDS, PROCESS FOR THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS.
MA26436A1 (en) QUATERNARY AMMONIUM COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
DZ3050A1 (en) Polymorphic forms of a crystalline azobicydoÄ2,2,2Ü-octane-3-amine citrate and their pharmaceutical compositions.
FR2677355B1 (en) NEW OXAZOLE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2676224B1 (en) NOVEL QUATERNARY AMMONIUM SALTS, PROCESSES FOR OBTAINING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
FR2692578B1 (en) INDOLIZIN DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF FOR THE PREPARATION OF AMINOALKOXYBENZENESULFONYL-INDOLIZINE COMPOUNDS WITH PHARMACEUTICAL ACTIVITY.
IT1167746B (en) NITROIMIDAZOLI WITH TRICOMONACID ACTIVITY, PROCEDURE FOR THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS
FR2526432B1 (en) TETRAHYDROBENZOTHIAZOLE DERIVATIVE AND HERBICIDE COMPOSITION CONTAINING THE SAME, AS ACTIVE INGREDIENT

Legal Events

Date Code Title Description
ST Notification of lapse
TP Transmission of property
ST Notification of lapse

Effective date: 20060131